Anticancer composition comprising cervical cancer-derived autocrine motility factor as effective component
US11123402B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 4, 2018 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Oct 21, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anticancer composition includes cervical cancer-derived autocrine motility factor (AMF) as an effective component. The cervical cancer-derived AMF has an excellent effect of inhibiting the proliferation of liver cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and colon cancer, and inducing cell death. The composition can be used as an anticancer therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.